Study on recent polymyalgia rheumatica diagnosis and outcomes
Part of Bones, joints & muscles, Infections, Skin clinical trials.
This study looks at patients who have been recently diagnosed with polymyalgia rheumatica (PPR) and are starting steroid treatment. It aims to understand how the disease progresses over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You have pain in your shoulders and/or hips that is caused by inflammation.
- Your C-reactive protein (CRP) level is 10 mg/L or higher, which indicates inflammation in your body.
- Your rheumatologist has confirmed you have polymyalgia rheumatica (PPR) and has prescribed steroids for it.
- Your symptoms started within the last 24 weeks (about 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune system and genetic (inherited) differences in people diagnosed with giant cell arteritis or polymyalgia rheumatica. It aims to improve understanding of why these conditions happen and how they vary between people.
This trial tests whether the drug sarilumab can help people with newly diagnosed or early relapsing polymyalgia rheumatica (PMR) reduce their need for prednisone. It aims to see if the combination is safer and more effective than prednisone alone.
This study is looking for biomarkers (biological clues) in people with newly diagnosed or flaring giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). Participating may help researchers find better ways to diagnose and monitor these conditions.
This study looks at how well a special PET scan (18-FDG PET-CT) can help doctors diagnose polymyalgia rheumatica, a type of inflammatory arthritis. If you have had this scan and were diagnosed with an inflammatory rheumatism by a specialist, your data could help improve diagnosis for others.
This study tests whether a daily pill (tofacitinib) combined with a short course of steroids can help people with active PMR use less steroids over time. You must have high disease activity and not have taken steroids or biologics in the past two weeks.
This study follows people with a first episode of peripheral (hand/foot/arm/leg) arthritis that seems to be psoriatic arthritis. It aims to improve understanding of early disease and may help guide more personalized care over time.
Hear when a new Polymyalgia Rheumatica trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.